Actavis Laboratories FL, Inc. dba Teva Pharmaceuticals

Form 483

Issued to: Andrx Pharmaceuticals, Inc

Davie, Florida, United StatesFEI 3003194604Issued July 24, 2015

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003194604.

Observations9

Issue DateJuly 24, 2015

StatusNo Warning Letter

Establishment TypePharmaceutical Manufacturer

Related Inspections9

Establishment Details

Firm: Actavis Laboratories FL, Inc. dba Teva Pharmaceuticals
Issued To: Andrx Pharmaceuticals, Inc
Location: Davie, Florida, United States
FEI Number: 3003194604
Establishment Type: Pharmaceutical Manufacturer
Product Type: Drugs
Issue Date: July 24, 2015
Country: United States

Inspection History, 2009 to 2025

VAI7

OAI2

VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Actavis Laboratories FL, Inc. dba Teva Pharmaceuticals FDA Form 483, Davie, Florida, July 24, 2015